The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids
Authors:
- Emerson de OliveiraEOEmerson de Oliveira
- Rodrigo de Aquino CastroRCRodrigo de Aquino Castro
- Mariano Tamura Vieira GomesMGMariano Tamura Vieira Gomes
- Ismael Dale Cotrim Guerreiro da SilvaISIsmael Dale Cotrim Guerreiro da Silva
- Edmund Chada BaracatEBEdmund Chada Baracat
- Geraldo Rodrigues de LimaGLGeraldo Rodrigues de Lima
- Marair Gracio Ferreira SartoriMSMarair Gracio Ferreira Sartori
- Manoel João Batista Castello GirãoMGManoel João Batista Castello Girão
- 1 July 2008
- Vol. 60 (3-4) , 235-238
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Uterine Fibroids: The Elephant in the RoomScience, 2005
- Molecular Biology of Inhibin ActionSeminars in Reproductive Medicine, 2004
- Sex steroidal regulation of uterine leiomyoma growth and apoptosisHuman Reproduction Update, 2004
- Color and genomic ancestry in BraziliansProceedings of the National Academy of Sciences, 2002
- Uterine fibroidsThe Lancet, 2001
- Functional role of estrogen metabolism in target cells: review and perspectivesCarcinogenesis, 1998
- Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiatorsProceedings of the National Academy of Sciences, 1997
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Molecular Mechanisms of Estrogen CarcinogenesisAnnual Review of Pharmacology and Toxicology, 1996
- P450 enzymes of estrogen metabolismPharmacology & Therapeutics, 1993